The MarketWatch News Section was not included in the creation of this articles.
AbCellera (Nasdaq: ABCL) will announce its fourth-quarter and full-year 2020 economical final results on Monday, March 29, 2021 just after the U.S. inventory marketplaces close and keep an earnings conference contact at 2:00 p.m. Pacific Time (5:00 p.m. Japanese Time) the exact same day.
The reside webcast of the earnings conference phone can be accessed by means of a url that will be posted on AbCellera’s Investor Relations web-site. A replay of the webcast will be accessible via the exact same link adhering to the convention connect with.
About AbCellera Biologics Inc.
AbCellera is a know-how corporation that searches, decodes, and analyzes organic immune systems to locate antibodies that its partners can create into prescription drugs to avoid and treat disorder. AbCellera associates with drug developers of all sizes, from large pharmaceutical to tiny biotechnology companies, empowering them to shift speedily, cut down expense, and tackle the hardest problems in drug advancement. For far more details, check out www.abcellera.com.
AbCellera Forward-searching Statements
This push launch includes ahead-searching statements, which includes statements designed pursuant to the protected harbor provisions of the Non-public Securities Litigation Reform Act of 1995. The forward-looking statements are primarily based on management’s beliefs and assumptions and on details currently obtainable to administration. All statements contained in this release other than statements of historic fact are ahead-looking statements, which includes statements concerning our means to create, commercialize and reach marketplace acceptance of our existing and planned products and expert services, our study and development initiatives, and other issues pertaining to our business enterprise procedures, use of cash, outcomes of functions and monetary position, and options and aims for future functions.
In some instances, you can determine forward-searching statements by the words and phrases “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the detrimental of these terms or other comparable terminology, whilst not all forward-searching statements have these words. These statements contain pitfalls, uncertainties and other elements that may result in actual effects, amounts of exercise, efficiency, or achievements to be materially various from the info expressed or implied by these ahead-hunting statements. These challenges, uncertainties and other aspects are explained beneath “Risk Factors,” “Management’s Dialogue and Assessment of Economic Condition and Final results of Operations” and elsewhere in the paperwork we file with the Securities and Exchange Commission from time to time. We caution you that forward-on the lookout statements are dependent on a mixture of facts and variables presently regarded by us and our projections of the future, about which we are not able to be selected. As a result, the forward-looking statements might not confirm to be correct. The ahead-hunting statements in this push launch depict our sights as of the date hereof. We undertake no obligation to update any forward-hunting statements for any purpose, besides as expected by regulation.
Watch source version on businesswire.com: https://www.businesswire.com/news/house/20210203005894/en/
Source: AbCellera Biologics Inc.
InquiriesMedia: Jessica Yingling, Ph.D. [email protected], +1(236)521-6774
Organization Advancement: Kevin Heyries, Ph.D. [email protected], +1(604)559-9005
Investor Relations: Melanie Solomon [email protected], +1(778)729-9116
Copyright Company Wire 2021
The MarketWatch Information Division was not associated in the creation of this content.